TNF and inflammatory bowel disease: For example, the combined therapy of anti-TNF-α and thiopurines in IBD has been proven to be superior to monotherapy in induction and maintenance of response due to decreased antibody formation against anti-TNF-α agents, increased response rate, and prolonged drug survival (19).